Lymph node paradoxical enlargement during treatment for tuberculous spondylodiscitis (Pott's disease)

Joint Bone Spine

Volumn 74, Issue 3, 2007, Pages 292-295

  Froissart, Antoine ^a   Pagnoux, Christian ^b   Chérin, Patrick ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Institut Cochin   (France)

Author keywords

Paradoxical reaction; Pott's disease; Tuberculosis; Tuberculous spondylodiscitis

Indexed keywords

ANTIMYCOBACTERIAL AGENT; C REACTIVE PROTEIN; CORTICOSTEROID DERIVATIVE; ETHAMBUTOL; HEMOGLOBIN; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; ANAMNESIS; ARTICLE; BONE BIOPSY; BONE NECROSIS; BONE TUMOR; CASE REPORT; CELLULAR IMMUNITY; CERVICAL LYMPH NODE; CLINICAL EXAMINATION; CLINICAL FEATURE; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATION; INTERVERTEBRAL DISK DEGENERATION; LABORATORY TEST; LYMPHADENOPATHY; MICROCYTIC ANEMIA; MYCOBACTERIUM TUBERCULOSIS; OSTEOARTHRITIS; PERCUTANEOUS DRAINAGE; TISSUE INJURY; TREATMENT OUTCOME; TUBERCULOUS SPONDYLITIS; VERTEBRA BODY; VERTEBRA MALFORMATION;

ADRENAL CORTEX HORMONES; ANTITUBERCULAR AGENTS; DRAINAGE; FEMALE; HUMANS; LYMPH NODES; MIDDLE AGED; NECK; TOMOGRAPHY, X-RAY COMPUTED; TUBERCULOSIS, SPINAL;

EID: 34248189715     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2006.06.010     Document Type: Article

References (15)

1. Tali E.T. Spinal infections. Eur J Radiol 50 (2004) 120-133
2. Taylor Z., Nolan C.M., and Blumberg H.M. Controlling tuberculosis in the United States. Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America. MMWR Recomm Rep 54 (2005) 1-81
3. Cheng V.C., Yam W.C., Woo P.C., Lau S.K., Hung I.F., Wong S.P., et al. Risk factors for development of paradoxical response during antituberculosis therapy in HIV-negative patients. Eur J Clin Microbiol Infect Dis 22 (2003) 597-602
4. Memish Z.A., Mah M.W., Mahmood S.A., Bannatyne R.M., and Khan M.Y. Clinico-diagnostic experience with tuberculous lymphadenitis in Saudi Arabia. Clin Microbiol Infect 6 (2000) 137-141
5. Geldmacher H., Taube C., Kroeger C., Magnussen H., and Kirsten D.K. Assessment of lymph node tuberculosis in northern Germany: a clinical review. Chest 121 (2002) 1177-1182
6. Narita M., Ashkin D., Hollender E.S., and Pitchenik A.E. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med 158 (1998) 157-161
7. Breen R.A., Smith C.J., Bettinson H., Dart S., Bannister B., Johnson M.A., et al. Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection. Thorax 59 (2004) 704-707
8. Hirsch C.S., Toossi Z., Othieno C., Johnson J.L., Schwander S.K., Robertson S., et al. Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy. J Infect Dis 180 (1999) 2069-2073
9. Hirsch C.S., Johnson J.L., Okwera A., Kanost R.A., Wu M., Peters P., et al. Mechanisms of apoptosis of T-cells in human tuberculosis. J Clin Immunol 25 (2005) 353-364
10. Vanham G., Toossi Z., Hirsch C.S., Wallis R.S., Schwander S.K., Rich E.A., et al. Examining a paradox in the pathogenesis of human pulmonary tuberculosis: immune activation and suppression/anergy. Tuber Lung Dis 78 (1997) 145-158
11. Cheng V.C., Yuen K.Y., Wong S.S., Woo P.C., Ho P.L., Lee R., et al. Immunorestitution diseases in patients not infected with HIV. Eur J Clin Microbiol Infect Dis 20 (2001) 402-406
12. Pagnoux C., Genereau T., Lafitte F., Congy F., Chiras J., and Herson S. Brain tuberculomas. Ann Med Interne (Paris) 151 (2000) 448-455
13. Jha B.C., Dass A., Nagarkar N.M., Gupta R., and Singhal S. Cervical tuberculous lymphadenopathy: changing clinical pattern and concepts in management. Postgrad Med J 77 (2001) 185-187
14. Dooley D.P., Carpenter J.L., and Rademacher S. Adjunctive corticosteroid therapy for tuberculosis: a critical reappraisal of the literature. Clin Infect Dis 25 (1997) 872-887
15. Chan H.S., and Pang J.A. Effect of corticosteroids on deterioration of endobronchial tuberculosis during chemotherapy. Chest 96 (1989) 1195-1196